ORIC Pharmaceuticals Statistics

Total Valuation

ORIC has a market cap or net worth of $651.17 million. The enterprise value is $456.16 million.

Market Cap	651.17M
Enterprise Value	456.16M

Important Dates

The last earnings date was Monday, May 5, 2025, after market close.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

ORIC has 71.09 million shares outstanding. The number of shares has increased by 23.91% in one year.

Current Share Class	71.09M
Shares Outstanding	71.09M
Shares Change (YoY)	+23.91%
Shares Change (QoQ)	+0.55%
Owned by Insiders (%)	2.00%
Owned by Institutions (%)	83.00%
Float	45.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.96
P/TBV Ratio	2.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.00, with a Debt / Equity ratio of 0.04.

Current Ratio	12.00
Quick Ratio	11.56
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -48.45% and return on invested capital (ROIC) is -32.34%.

Return on Equity (ROE)	-48.45%
Return on Assets (ROA)	-30.87%
Return on Invested Capital (ROIC)	-32.34%
Return on Capital Employed (ROCE)	-65.10%
Revenue Per Employee	n/a
Profits Per Employee	-$1.16M
Employee Count	115
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.77% in the last 52 weeks. The beta is 1.36, so ORIC's price volatility has been higher than the market average.

Beta (5Y)	1.36
52-Week Price Change	+5.77%
50-Day Moving Average	5.68
200-Day Moving Average	8.37
Relative Strength Index (RSI)	76.67
Average Volume (20 Days)	1,873,586

Short Selling Information

The latest short interest is 11.69 million, so 16.44% of the outstanding shares have been sold short.

Short Interest	11.69M
Short Previous Month	11.19M
Short % of Shares Out	16.44%
Short % of Float	25.50%
Short Ratio (days to cover)	19.92

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-146.62M
Pretax Income	-101.76M
Net Income	-132.86M
EBITDA	-145.48M
EBIT	-146.62M
Earnings Per Share (EPS)	-$1.88

Full Income Statement

Balance Sheet

The company has $203.72 million in cash and $8.72 million in debt, giving a net cash position of $195.01 million or $2.74 per share.

Cash & Cash Equivalents	203.72M
Total Debt	8.72M
Net Cash	195.01M
Net Cash Per Share	$2.74
Equity (Book Value)	219.74M
Book Value Per Share	3.09
Working Capital	193.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$115.01 million and capital expenditures -$1.36 million, giving a free cash flow of -$116.37 million.

Operating Cash Flow	-115.01M
Capital Expenditures	-1.36M
Free Cash Flow	-116.37M
FCF Per Share	-$1.64

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.91%
Shareholder Yield	-23.91%
Earnings Yield	-20.40%
FCF Yield	-17.87%

Analyst Forecast

The average price target for ORIC is $18.83, which is 105.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.83
Price Target Difference	105.57%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-8.31%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1